IMA Advisory Services’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-350
Closed 328
2020
Q4
$0 Sell
350
-17
-5% -$36 ﹤0.01% 332
2020
Q3
$1K Buy
367
+17
+5% +$49 ﹤0.01% 294
2020
Q2
$1K Hold
350
﹤0.01% 243
2020
Q1
$1K Hold
350
﹤0.01% 249
2019
Q4
$1K Buy
+350
New +$910 ﹤0.01% 280

Other funds holding BMY.RT

IMA Advisory Services's BMY.RT Position: Q1 2021 in Review

IMA Advisory Services sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q1 2021, closing a stake of 350 shares.

IMA Advisory Services first reported a position in BMY.RT in Q4 2019 and held it in 5 quarters. The position peaked at $1K in Q3 2020. 12 funds tracked by Wall St. Rank hold BMY.RT as of Q1 2021.

  • IMA Advisory Services reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q1 2021 after selling out during the quarter.
  • IMA Advisory Services sold 350 Bristol-Myers Squibb Company Contingent Value Rights shares in Q1 2021.
  • IMA Advisory Services first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q4 2019 and held it in 5 quarters.
  • IMA Advisory Services's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $1K in Q3 2020.
  • 12 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q1 2021.

Based on IMA Advisory Services's 13F filing for Q1 2021, filed 13 May 2021.